Abstract
As proteomics technologies develop, increasing number of membrane-associated proteins specific for cancer cells are being discovered. These proteins are of great interest, particularly because they are rich in targets for antibodies. Amongst them candidate biomarkers for early tumor diagnosis, prognosis and treatment have been detected. The suitability of several membrane-associated proteins as targets for drugs or antibodies has already been tested in preclinical and clinical studies. The results were encouraging in some cases, but not in all. They demonstrate that each type of tumor has its specific “Achilles heel”, and that suitable targets of cancer diagnosis and therapy must be found for each kind of neoplasm. This implies that membrane-associated proteins for each type of tumor cell need to be investigated. This review describes the current technologies of membrane protein characterization in a first part and subsequently summarizes the membrane associated proteins currently being tested as targets for diagnosis and treatment in breast, prostate, thyroid, and colon cancer. Their function will be explained and their role in tumor biology will be discussed.
Keywords: Proteomics, biomarker, thyroid cancer, breast cancer, colorectal cancer, prostate cancer, proteomics technologies, Achilles heel, neoplasm, Helicobacter pylori, papilloma virus, lipid bilayer, eukaryotic cells, carbohydrate moieties, tumorigenesis, malignant cell, Liquid chromatography, mass spectrometry, laser microdissection, isoelectric focusing, cytosolic proteins, 2D electrophoresis, biotinylation, Immunological methods, malignant cells, Paclitaxel, Trastuzuma, Ertumaxomab, heat shock pro-tein 90, R-Flurbiprofen, Ibuprofen, hormone-refractory prostate cancer (HRPC), tumor neovascularization, thyroid stimulating hormone (TSH), thyroid gland, thyrotrophin, radiotherapy, para-follicular, C cells, somatostatin receptor, tyrosine kinases, carcinoembryonic antigen, glycoprotein A33, metastasis, immunoglobulin, glycosylphosphatidylinositol, threonine residues, N-acetyl-glucosamine, hyaluronan, Lapatinib, Neratinib, Sunitinib, Bevacizumab, Cetuximab, Panitumumab, iodine transporters
Current Medicinal Chemistry
Title: Diagnostic and Therapeutic Use of Membrane Proteins in Cancer Cells
Volume: 18 Issue: 2
Author(s): D. Grimm, J. Bauer, J. Pietsch, M. Infanger, J. Eucker, C. Eilles and J. Schoenberger
Affiliation:
Keywords: Proteomics, biomarker, thyroid cancer, breast cancer, colorectal cancer, prostate cancer, proteomics technologies, Achilles heel, neoplasm, Helicobacter pylori, papilloma virus, lipid bilayer, eukaryotic cells, carbohydrate moieties, tumorigenesis, malignant cell, Liquid chromatography, mass spectrometry, laser microdissection, isoelectric focusing, cytosolic proteins, 2D electrophoresis, biotinylation, Immunological methods, malignant cells, Paclitaxel, Trastuzuma, Ertumaxomab, heat shock pro-tein 90, R-Flurbiprofen, Ibuprofen, hormone-refractory prostate cancer (HRPC), tumor neovascularization, thyroid stimulating hormone (TSH), thyroid gland, thyrotrophin, radiotherapy, para-follicular, C cells, somatostatin receptor, tyrosine kinases, carcinoembryonic antigen, glycoprotein A33, metastasis, immunoglobulin, glycosylphosphatidylinositol, threonine residues, N-acetyl-glucosamine, hyaluronan, Lapatinib, Neratinib, Sunitinib, Bevacizumab, Cetuximab, Panitumumab, iodine transporters
Abstract: As proteomics technologies develop, increasing number of membrane-associated proteins specific for cancer cells are being discovered. These proteins are of great interest, particularly because they are rich in targets for antibodies. Amongst them candidate biomarkers for early tumor diagnosis, prognosis and treatment have been detected. The suitability of several membrane-associated proteins as targets for drugs or antibodies has already been tested in preclinical and clinical studies. The results were encouraging in some cases, but not in all. They demonstrate that each type of tumor has its specific “Achilles heel”, and that suitable targets of cancer diagnosis and therapy must be found for each kind of neoplasm. This implies that membrane-associated proteins for each type of tumor cell need to be investigated. This review describes the current technologies of membrane protein characterization in a first part and subsequently summarizes the membrane associated proteins currently being tested as targets for diagnosis and treatment in breast, prostate, thyroid, and colon cancer. Their function will be explained and their role in tumor biology will be discussed.
Export Options
About this article
Cite this article as:
Grimm D., Bauer J., Pietsch J., Infanger M., Eucker J., Eilles C. and Schoenberger J., Diagnostic and Therapeutic Use of Membrane Proteins in Cancer Cells, Current Medicinal Chemistry 2011; 18 (2) . https://dx.doi.org/10.2174/092986711794088344
DOI https://dx.doi.org/10.2174/092986711794088344 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Approaches to the treatment of chronic inflammation
Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Current Evidence from Phase III Clinical Trials of Selenium Supplementation in Critically Ill Patients: Why Should We Bother?
Mini-Reviews in Medicinal Chemistry Hyperglycaemia and Vitamin D: A Systematic Overview
Current Diabetes Reviews Withdrawal Notice: Drug Repurposing for Prospective Anti-Cancer Agents Along with the Clinical Status of the Repurposed Drug
Anti-Cancer Agents in Medicinal Chemistry Recent Inventions on Receptor Tyrosine Kinase RET Modulation
Recent Patents on Biotechnology Role of Nuclear Steroid Receptors in Apoptosis
Current Medicinal Chemistry Zinc, Metallothioneins and Longevity: Interrelationships with Niacin and Selenium
Current Pharmaceutical Design Selenoproteins and their Role in Oxidative Stress and Inflammation
Current Chemical Biology Repurposing of Anticancer Drugs for the Treatment of Bacterial Infections
Current Topics in Medicinal Chemistry The Use of Ghrelin and Ghrelin Receptor Agonists as a Treatment for Animal Models of Disease: Efficacy and Mechanism
Current Pharmaceutical Design Novel Homeodomain Transcription Factor Nkx2.2 in the Brain Tumor Development
Current Cancer Drug Targets Selective VEGFR Inhibitors for Anticancer Therapeutics in Clinical Use and Clinical Trials
Current Pharmaceutical Design The Possible Role of Infertility Drugs in Later Malignancy: A Review
Current Medicinal Chemistry Suppression of Erosive Arthritis by NF-κB Inhibitors
Current Rheumatology Reviews The TGF-β 1/Foxp3 Regulatory Axis in Immune Self-Tolerance: Implications for Health and Disease
Inflammation & Allergy - Drug Targets (Discontinued) The Development of Targeted Therapies for Hepatocellular Cancer
Current Pharmaceutical Design Rational Combination of Targeted Therapies As A Strategy to Overcome The Mechanisms of Resistance to Inhibitors of EGFR Signaling
Current Pharmaceutical Design Beneficial and Adverse Effects of Molecularly Targeted Therapies for Acute Promyelocytic Leukemia in Central Nervous System
CNS & Neurological Disorders - Drug Targets Targeting Strategies to Modulate the NF-κB and JNK Signal Transduction Network
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Patents on Enhancing the Potency and Longevity of Highly Valuable Protein Hormones
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Tumor-Derived Extracellular Fragments of Receptor Protein Tyrosine Phosphatases (RPTPs) as Cancer Molecular Diagnostic Tools
Anti-Cancer Agents in Medicinal Chemistry